Logo image of HBI

HANESBRANDS INC (HBI) Stock Fundamental Analysis

NYSE:HBI - New York Stock Exchange, Inc. - US4103451021 - Common Stock - Currency: USD

4.66  +0.05 (+1.08%)

After market: 4.66 0 (0%)

Fundamental Rating

3

Overall HBI gets a fundamental rating of 3 out of 10. We evaluated HBI against 49 industry peers in the Textiles, Apparel & Luxury Goods industry. HBI may be in some trouble as it scores bad on both profitability and health. A decent growth rate in combination with a cheap valuation! Better keep an eye on HBI.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year HBI was profitable.
In the past year HBI had a positive cash flow from operations.
In the past 5 years HBI reported 4 times negative net income.
Of the past 5 years HBI 4 years had a positive operating cash flow.
HBI Yearly Net Income VS EBIT VS OCF VS FCFHBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

HBI has a worse Return On Assets (-7.61%) than 71.43% of its industry peers.
HBI's Return On Equity of -669.26% is on the low side compared to the rest of the industry. HBI is outperformed by 89.80% of its industry peers.
The Return On Invested Capital of HBI (12.87%) is better than 77.55% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HBI is below the industry average of 11.45%.
The last Return On Invested Capital (12.87%) for HBI is above the 3 year average (9.25%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -7.61%
ROE -669.26%
ROIC 12.87%
ROA(3y)-3.54%
ROA(5y)-2.1%
ROE(3y)-326.11%
ROE(5y)-195.33%
ROIC(3y)9.25%
ROIC(5y)10.86%
HBI Yearly ROA, ROE, ROICHBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

HBI's Operating Margin of 12.67% is amongst the best of the industry. HBI outperforms 81.63% of its industry peers.
HBI's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 41.77%, HBI is not doing good in the industry: 67.35% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of HBI has remained more or less at the same level.
Industry RankSector Rank
OM 12.67%
PM (TTM) N/A
GM 41.77%
OM growth 3Y-4.92%
OM growth 5Y-3.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y1.34%
HBI Yearly Profit, Operating, Gross MarginsHBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HBI is creating some value.
The number of shares outstanding for HBI has been increased compared to 1 year ago.
The number of shares outstanding for HBI has been reduced compared to 5 years ago.
HBI has a worse debt/assets ratio than last year.
HBI Yearly Shares OutstandingHBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
HBI Yearly Total Debt VS Total AssetsHBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 1.83 indicates that HBI is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of HBI (1.83) is worse than 77.55% of its industry peers.
HBI has a debt to FCF ratio of 23.24. This is a negative value and a sign of low solvency as HBI would need 23.24 years to pay back of all of its debts.
HBI has a worse Debt to FCF ratio (23.24) than 63.27% of its industry peers.
HBI has a Debt/Equity ratio of 53.45. This is a high value indicating a heavy dependency on external financing.
HBI has a Debt to Equity ratio of 53.45. This is amonst the worse of the industry: HBI underperforms 93.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 53.45
Debt/FCF 23.24
Altman-Z 1.83
ROIC/WACC1.3
WACC9.9%
HBI Yearly LT Debt VS Equity VS FCFHBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.55 indicates that HBI should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.55, HBI is doing worse than 67.35% of the companies in the same industry.
A Quick Ratio of 0.67 indicates that HBI may have some problems paying its short term obligations.
With a Quick ratio value of 0.67, HBI is not doing good in the industry: 79.59% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 0.67
HBI Yearly Current Assets VS Current LiabilitesHBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

HBI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 440.00%, which is quite impressive.
Measured over the past years, HBI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -23.96% on average per year.
HBI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.56%.
The Revenue for HBI have been decreasing by -11.40% on average. This is quite bad
EPS 1Y (TTM)440%
EPS 3Y-37.35%
EPS 5Y-23.96%
EPS Q2Q%450%
Revenue 1Y (TTM)-30.56%
Revenue growth 3Y-19.81%
Revenue growth 5Y-11.4%
Sales Q2Q%-34.25%

3.2 Future

The Earnings Per Share is expected to grow by 14.58% on average over the next years. This is quite good.
HBI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.87% yearly.
EPS Next Y21.72%
EPS Next 2Y15.11%
EPS Next 3Y13.68%
EPS Next 5Y14.58%
Revenue Next Year-3.32%
Revenue Next 2Y-1.94%
Revenue Next 3Y-1.02%
Revenue Next 5Y0.87%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HBI Yearly Revenue VS EstimatesHBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
HBI Yearly EPS VS EstimatesHBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0.5 1 1.5

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.63, the valuation of HBI can be described as reasonable.
Based on the Price/Earnings ratio, HBI is valued cheaply inside the industry as 85.71% of the companies are valued more expensively.
HBI is valuated cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 7.82, the valuation of HBI can be described as very cheap.
Based on the Price/Forward Earnings ratio, HBI is valued cheaper than 89.80% of the companies in the same industry.
HBI is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.63
Fwd PE 7.82
HBI Price Earnings VS Forward Price EarningsHBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HBI is valued a bit cheaper than the industry average as 73.47% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, HBI is valued a bit cheaper than the industry average as 63.27% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 16.31
EV/EBITDA 7.34
HBI Per share dataHBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5

4.3 Compensation for Growth

HBI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HBI's earnings are expected to grow with 13.68% in the coming years.
PEG (NY)0.4
PEG (5Y)N/A
EPS Next 2Y15.11%
EPS Next 3Y13.68%

0

5. Dividend

5.1 Amount

HBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HANESBRANDS INC

NYSE:HBI (7/8/2025, 8:04:00 PM)

After market: 4.66 0 (0%)

4.66

+0.05 (+1.08%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners93.02%
Inst Owner Change0%
Ins Owners1.12%
Ins Owner Change4.61%
Market Cap1.65B
Analysts50.77
Price Target5.51 (18.24%)
Short Float %10.69%
Short Ratio7.09
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)117.65%
Min EPS beat(2)17.38%
Max EPS beat(2)217.92%
EPS beat(4)4
Avg EPS beat(4)78.8%
Min EPS beat(4)17.38%
Max EPS beat(4)217.92%
EPS beat(8)6
Avg EPS beat(8)45.62%
EPS beat(12)8
Avg EPS beat(12)30.73%
EPS beat(16)11
Avg EPS beat(16)26.04%
Revenue beat(2)1
Avg Revenue beat(2)-3.69%
Min Revenue beat(2)-7.43%
Max Revenue beat(2)0.05%
Revenue beat(4)1
Avg Revenue beat(4)-10.83%
Min Revenue beat(4)-27.34%
Max Revenue beat(4)0.05%
Revenue beat(8)1
Avg Revenue beat(8)-7.24%
Revenue beat(12)2
Avg Revenue beat(12)-5.92%
Revenue beat(16)4
Avg Revenue beat(16)-3.95%
PT rev (1m)10.2%
PT rev (3m)-14.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.68%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.28%
Valuation
Industry RankSector Rank
PE 8.63
Fwd PE 7.82
P/S 0.47
P/FCF 16.31
P/OCF 12.69
P/B 37.93
P/tB N/A
EV/EBITDA 7.34
EPS(TTM)0.54
EY11.59%
EPS(NY)0.6
Fwd EY12.79%
FCF(TTM)0.29
FCFY6.13%
OCF(TTM)0.37
OCFY7.88%
SpS9.87
BVpS0.12
TBVpS-4.2
PEG (NY)0.4
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.61%
ROE -669.26%
ROCE 16.29%
ROIC 12.87%
ROICexc 13.76%
ROICexgc 34.66%
OM 12.67%
PM (TTM) N/A
GM 41.77%
FCFM 2.89%
ROA(3y)-3.54%
ROA(5y)-2.1%
ROE(3y)-326.11%
ROE(5y)-195.33%
ROIC(3y)9.25%
ROIC(5y)10.86%
ROICexc(3y)9.89%
ROICexc(5y)12.07%
ROICexgc(3y)24.54%
ROICexgc(5y)28.18%
ROCE(3y)11.7%
ROCE(5y)13.75%
ROICexcg growth 3Y-1.22%
ROICexcg growth 5Y5.88%
ROICexc growth 3Y-7.77%
ROICexc growth 5Y0.09%
OM growth 3Y-4.92%
OM growth 5Y-3.59%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.86%
GM growth 5Y1.34%
F-Score4
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 53.45
Debt/FCF 23.24
Debt/EBITDA 4.46
Cap/Depr 37.03%
Cap/Sales 0.83%
Interest Coverage 250
Cash Conversion 24.97%
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 0.67
Altman-Z 1.83
F-Score4
WACC9.9%
ROIC/WACC1.3
Cap/Depr(3y)95.15%
Cap/Depr(5y)77.33%
Cap/Sales(3y)1.91%
Cap/Sales(5y)1.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)440%
EPS 3Y-37.35%
EPS 5Y-23.96%
EPS Q2Q%450%
EPS Next Y21.72%
EPS Next 2Y15.11%
EPS Next 3Y13.68%
EPS Next 5Y14.58%
Revenue 1Y (TTM)-30.56%
Revenue growth 3Y-19.81%
Revenue growth 5Y-11.4%
Sales Q2Q%-34.25%
Revenue Next Year-3.32%
Revenue Next 2Y-1.94%
Revenue Next 3Y-1.02%
Revenue Next 5Y0.87%
EBIT growth 1Y11.81%
EBIT growth 3Y-23.76%
EBIT growth 5Y-14.59%
EBIT Next Year26.54%
EBIT Next 3Y9.56%
EBIT Next 5Y8.73%
FCF growth 1Y133.33%
FCF growth 3Y-25.8%
FCF growth 5Y-20.26%
OCF growth 1Y256.3%
OCF growth 3Y-24.88%
OCF growth 5Y-19.94%